文献速递免疫规划慢病防控与筛查卫生政策与健康促进

印第安纳州县级人乳头瘤病毒疫苗完成接种的相关因素

County-level correlates of completed HPV vaccination in Indiana.
PubMed 文献 · Vaccine · 2023-08-19

本研究利用印第安纳州免疫信息系统数据,评估2017或2018年启动HPV疫苗接种的9-14岁个体在县级层面的两剂系列完成率,并分析县级社会人口学与健康指标与完成率的关系。结果显示县级平均完成率为73%,范围55.7%至90.4%,完成率与人均初级保健提供者、乳腺X线筛查参与率、家庭收入中位数、预期寿命、部分大学教育居民比例、结肠镜检查及时率及流感疫苗接种率呈正相关。

要点

  • 印第安纳州县均HPV疫苗两剂系列完成率为73%,范围55.7%至90.4%。
  • 完成率与人均初级保健提供者、乳腺X线筛查参与率、家庭收入中位数正相关。
  • 完成率与预期寿命、部分大学教育比例、结肠镜检查及时率、流感疫苗接种率正相关。

核心结论

  • 印第安纳州各县HPV疫苗系列完成率差异大,且与反映医疗可及性和经济资源的县级指标相关。

研究设计与样本

  • 数据提取自印第安纳州卫生部管理的印第安纳免疫信息系统(IIS),所有疫苗提供者须报告19岁以下患者的所有免疫接种。
  • 纳入2017或2018年启动HPV疫苗接种时年龄9-14岁的所有印第安纳州儿童,完成情况评估至2020年10月,允许距首剂至少22个月的间隔。
  • 所有统计分析在县级层面进行。

主要发现

  • 在接种首剂疫苗的个体中,印第安纳州HPV疫苗系列完成率县均为73%,范围55.7%至90.4%。
  • 较高的系列完成率与人均初级保健提供者、医疗保险参保者乳腺X线筛查参与率、家庭收入中位数、预期寿命、部分大学教育居民比例、结肠镜检查及时成人比例及流感疫苗接种成人比例呈正相关。
  • 印第安纳州各县系列完成率存在广泛差异。
  • HPV系列完成率与县级社会人口学及健康指标相关,尤其是反映医疗可及性困难和缺乏经济资源的变量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Healthy People 2030 goal is for 80% of all adolescents to complete their HPV vaccination series. Per the 2021, National Immunization Survey-Teen (NIS-Teen), 61.7% of adolescents have completed the series, and Indiana lags below the national average (55.2%). The present study estimated the 2-dose HPV vaccine series completion rates across Indiana counties among individuals aged 9-14 years who received their first dose of vaccine and determined what factors were associated with series completion at the county level. The association of county-level sociodemographic and health measures with series completion was also examined. Data were extracted from the Indiana Immunization Information System (IIS), administered by the Indiana Department of Health. All vaccine providers are required to report all immunizations to the system for any patient under age 19 years. All Indiana children ages 9-14 years at the time of first dose who had initiated HPV vaccination in 2017 or 2018 were included. Two-dose series completion was evaluated through October of 2020, allowing a minimum gap of 22 months from first dose administration. All statistical analyses were conducted at the county-level. The Indiana HPV vaccination series completion rate among individuals that received the first dose was on average 73% across counties, ranging from 55.7% to 90.4%. Higher series completion was positively associated with primary care providers per capita, participation in mammography screening among Medicare enrollees, median household income, life expectancy, percentage of residents with some college, percentage of adults up-to-date with colonoscopy screening, and percentage of adults with flu vaccine. There was wide variability in series completion across Indiana counties. HPV series completion was associated with county-level sociodemographic and health measures, particularly variables reflecting difficulties with access to care and lack of financial resources.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Enujioke SC, Shedd-Steele R, Daggy J, et al. County-level correlates of completed HPV vaccination in Indiana. Vaccine. 2023. PMID: 37599142. doi:10.1016/j.vaccine.2023.07.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。